Galderma SA

General

Total Cases25

Active Cases1

Patents--

CourtsN.D. Texas D. Delaware C.D. California

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

L2

B

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
04/25/24	Galderma Laboratories LP v. Tolmar Inc 1:10-CV-00045 ( D. DE )	ACKNOWLEDGMENT OF RECEIPT of Defendant's trial exhibits. Acknowledgment filed by Adam Wyatt Poff on behalf of Defendant Tolmar Inc. (mpb) (Entered: 04/25/2024)
04/24/24	Galderma Laboratories LP v. Tolmar Inc 1:10-CV-00045 ( D. DE )	ACKNOWLEDGMENT OF RECEIPT of Plaintiffs' trial exhibits. Acknowledgment filed by Jack B. Blumenfeld on behalf of Plaintiffs. (mpb) (Entered: 04/24/2024)
04/24/24	Galderma Laboratories LP v. Tolmar Inc 1:10-CV-00045 ( D. DE )	Letter to Adam Wyatt Poff, from the Clerk of the Court, regarding the return of Defendant's trial exhibits. (mpb) (Entered: 04/24/2024)
04/24/24	Galderma Laboratories LP v. Tolmar Inc 1:10-CV-00045 ( D. DE )	Letter to Jack B. Blumenfeld, from the Clerk of the Court, regarding the return of Plaintiffs' trial exhibits. (mpb) (Entered: 04/24/2024)
09/01/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,. (Schnapp, Zachary) (Entered: 09/01/2023)
09/01/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023)
09/01/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	REDACTED VERSION of 446 Opening Brief in Support, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C)(Flynn, Michael) (Entered: 09/01/2023)
08/28/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	ORDER, Galderma's Motion For Default Judgment (D.I. 445 ) is DENIED WITHOUT PREJUDICE pending final resolution of the claims against the Individual Defendants. The Parties' Joint Motion To Seal (D.I. 457 ) is GRANTED IN PART and DENIED IN PART as follows: The Motion is GRANTED as to Galderma's proposed redactions; the Motion is DENIED as to the Individual Defendants' proposed redactions. The Parties' Joint Motion To Seal Their Motion To Seal (D.I. 458 ) is GRANTED IN PART and DENIED IN PART to the same extent as their Motion To Seal. On or before September 1, 2023, the Individual Defendants shall file unredacted versions of any materials for which I have denied leave to file under seal. (See Order for further details). Signed by Judge Joshua D. Wolson on 8/28/2023. (twk) (Entered: 08/28/2023) ORDER, Galderma's Motion For Default Judgment (D.I. 445 ) is DENIED WITHOUT PREJUDICE pending final resolution of the claims against the Individual Defendants. The Parties' Joint Motion To Seal (D.I. 457 ) is GRANTED IN PART and DENIED IN PART as follows: The Motion is GRANTED as to Galderma's proposed redactions; the Motion is DENIED as to the Individual Defendants' proposed redactions. The Parties' Joint Motion To Seal Their Motion To Seal (D.I. 458 ) is GRANTED IN PART and DENIED IN PART to the same extent as their Motion To Seal. On or before September 1, 2023, the Individual Defendants shall file unredacted versions of any materials for which I have denied leave to file under seal. (See Order for further details). Signed by Judge Joshua D. Wolson on 8/28/2023. (twk) (Entered: 08/28/2023)
08/17/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	Joint MOTION to Seal Document: 457 Joint MOTION to Seal Document: 446 Opening Brief in Support, 452 Reply Brief, // Joint Motion to Seal Portions of Galderma's Opening and Reply Brief in Support of Its Motion for Entry of Default Judgment - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 08/17/2023)
08/17/23	Galderma Laboratories LP v. Medinter US LLC 1:18-CV-01892 ( D. DE )	[SEALED] Joint MOTION to Seal Document: 446 Opening Brief in Support, 452 Reply Brief, // Joint Motion to Seal Portions of Galderma's Opening and Reply Brief in Support of Its Motion for Entry of Default Judgment - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exhibit A - Declaration of David Banchik, # 2 Exhibit B - Declaration of Joseph Mahoney, # 3 Exhibit 1 - 7-17-23 email, # 4 Exhibit 2 - redacted version of Ex. 6, # 5 Exhibit 3 - redacted version of Ex. 7, # 6 Exhibit 4 - redacted version of Ex. 65, # 7 Exhibit 5 - 7-19-23 email, # 8 Exhibit 6 - 7-20-23 email, # 9 Exhibit 7 - 7-21-23 email, # 10 Exhibit 8 - 8-9-23 email, # 11 Appendix 1 - Plaintiffs' Position, # 12 Appendix 2, part 1 - Individual Defendants' Position, # 13 Appendix 2, part 2 - Individual Defendants' Position, # 14 Appendix 3 - proposed redactions to Reply Brief)Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 08/17/2023) [SEALED] Joint MOTION to Seal Document: 446 Opening Brief in Support, 452 Reply Brief, // Joint Motion to Seal Portions of Galderma's Opening and Reply Brief in Support of Its Motion for Entry of Default Judgment - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exhibit A - Declaration of David Banchik, # 2 Exhibit B - Declaration of Joseph Mahoney, # 3 Exhibit 1 - 7-17-23 email, # 4 Exhibit 2 - redacted version of Ex. 6, # 5 Exhibit 3 - redacted version of Ex. 7, # 6 Exhibit 4 - redacted version of Ex. 65, # 7 Exhibit 5 - 7-19-23 email, # 8 Exhibit 6 - 7-20-23 email, # 9 Exhibit 7 - 7-21-23 email, # 10 Exhibit 8 - 8-9-23 email, # 11 Appendix 1 - Plaintiffs' Position, # 12 Appendix 2, part 1 - Individual Defendants' Position, # 13 Appendix 2, part 2 - Individual Defendants' Position, # 14 Appendix 3 - proposed redactions to Reply Brief)Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 08/17/2023)